Refusal of Hospital-Based Oral Cancer Treatment Driven by Health Beliefs in Pakistan: A Qualitative Study Authors: Muhammad Usman Amanat, Hutcha Sriplung, Wit Wichaidit, Supawadee Naorungroj, Duangporn Kerdpon Published: 2026 ABSTRACT AbstractObjectivesHospital-based treatment refusal among oral cancer (OC) patients remains poorly understood. No qualitative studies have examined this phenomenon specifically in OC. This study aimed to explore the beliefs and attitudes underlying treatment refusal among OC patients in Pakistan.MethodsWe conducted a theory-informed qualitative case study guided by the Health Belief Model (HBM) using purposive criterion sampling. Semistructured interviews were conducted with eight OC patients who refused hospital-based treatment, eight family members involved in decision-making, and three oral surgeons. Interviews were audio-recorded, transcribed verbatim, translated into English, and analysed using inductive thematic analysis. Emergent themes were subsequently interpreted in relation to HBM constructs using abductive, theory-informed pattern matching. Methodological rigour was enhanced through data source triangulation and member checking.ResultsFrom the 19 in-depth interviews, we identified seven interconnected themes underlying treatment refusal: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, self-efficacy, cues to action, and religious beliefs. Treatment refusal was shaped by fatalistic perceptions of cancer incurability, intense fears of treatment-related harm, and substantial financial, access, and role-related constraints. Strong family influence and trust in traditional and complementary medicine further reinforced these decisions. Religious interpretations functioned bidirectionally, reinforcing acceptance of divine destiny and legitimizing nonbiomedical healing pathways, while in some cases also supporting treatment-seeking through religious doctrine.ConclusionRefusal of hospital-based OC treatment reflects a culturally embedded decision-making process shaped by interacting sociocultural, religious, and structural factors. The findings support the applicability of the HBM in this context and inform the development of culturally responsive, communication-focused interventions in oral oncology.Clinical RelevanceRecognition of belief-driven treatment refusal can help clinicians tailor communication, address fears of treatment harm, and engage family and religious influences to improve acceptance of hospital-based OC care.Key words: Treatment refusal, Oral cancer, Case study, Health Belief Model, Pakistan Introduction Oral cancer (OC) presents a major public health challenge in Pakistan, characterized by late-stage diagnosis and poor survival. Existing research has predominantly focused on factors contributing to diagnostic delay.1, 2, 3 However, an important decision point occurs after diagnosis, when some patients refuse or discontinue hospital-based treatment. Although relatively uncommon, with reported refusal rates of approximately 1% to 1.7%, its consequences are disproportionately severe, including poorer prognosis.4, 5, 6 Khyber Pakhtunkhwa represents a sociocultural context in which treatment decisions are strongly influenced by family involvement, religious beliefs, reliance on traditional and complementary medicine (T&CM), and marked socioeconomic constraints.1,2 Compared with more urbanized and medically resourced settings, where biomedical literacy and healthcare access are comparatively greater, these factors more strongly shape health-related decision-making and amplify barriers to treatment acceptance. Evidence from the region indicates that OC pathways are frequently shaped by cultural interpretations of illness, nonbiomedical care-seeking, and access constraints.1,2,7 Research has shown that oral healthcare utilization and treatment-related behaviours are strongly influenced by sociocultural beliefs, trust in healthcare systems, and contextual barriers to care.8 We posit that these same sociocultural dynamics also shape the postdiagnostic phase, framing treatment refusal not as an isolated event but as the culmination of a broader decision-making trajectory influenced by family, community, and religious beliefs. Despite its clinical significance, the motivations underlying refusal of hospital-based treatment remain poorly understood. Existing evidence is largely derived from retrospective, database-based studies that identify refusal as a prognostic indicator of poorer survival, but rarely examine it as a decision-making process in its own right.4,5,9,10 While useful for estimating prevalence and outcomes, such approaches provide limited insight into patients’ subjective reasoning and the sociocultural, familial, and religious contexts in which refusal occurs. This limitation is reinforced by the scarcity of qualitative research focused specifically on OC. Existing qualitative studies typically address cancer care more broadly and do not examine OC-specific decision-making, particularly in the postdiagnostic phase.11 In addition, to our knowledge, no prior study has applied a theoretically informed qualitative framework to examine how multiple beliefs and perceptions converge in decisions to refuse OC treatment. Addressing this gap is essential for informing culturally appropriate communication and patient-centred care strategies. The Health Belief Model (HBM) is a well-established framework for understanding how perceptions and beliefs shape health-related decision-making, particularly when actions involve perceived risks, uncertainty, and trade-offs.12,13 It is well suited to examining complex treatment decisions in life-threatening conditions such as OC.14 In sociocultural contexts characterized by strong family involvement and religious embeddedness, the HBM provides a systematic lens to examine how patients interpret illness and evaluate treatment options. To address existing gaps, we used a qualitative approach guided by the HBM to explore how OC patients interpret their diagnosis, evaluate hospital-based treatment, and negotiate competing social, cultural, and religious influences. This framework enabled the examination of treatment refusal as a coherent, contextually grounded decision shaped by interacting beliefs and perceptions rather than as an isolated act of nonadherence. Our objective was to explore the beliefs and attitudes underlying refusal of hospital-based treatment among OC patients in Pakistan using the HBM as the primary theoretical framework. Materials and methods Study design and theoretical framework We conducted a theory-informed qualitative case study to explore the beliefs and decision-making processes underlying refusal of hospital-based treatment among OC patients. The case was bounded by this phenomenon within its sociocultural and healthcare context. The study was informed by the HBM, which guided the development of interview guides and the interpretive analysis across six constructs: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, self-efficacy, and cues to action (Supplementary Table 1). Study setting and participants Participants were identified through three tertiary care hospitals in Khyber Pakhtunkhwa, Pakistan, from May to September 2023. The study included OC patients who refused hospital-based treatment, one family member directly involved in the decision for each patient, and clinicians involved in their diagnostic or treatment pathway. Purposive criterion sampling sought variation in gender, age, and residence (Supplementary Figure 1). Eligible patients were adults (age 18 years or older) with histologically confirmed oral squamous cell carcinoma of the lip and oral cavity (ICD-10 C00-C06) who refused recommended hospital-based treatment.15 Patients with other head and neck cancer sites were not included. Family members and one clinician from each hospital were interviewed to provide complementary perspectives. Sample size was guided by the principle of information power, as the study addressed a narrowly defined and relatively rare phenomenon and involved highly specific participants with direct experience of treatment refusal.16 Data collection An initial list of potential participants was compiled using records and input from clinical staff across the three participating hospitals. Eligible patients were contacted by hospital staff, informed about the study, and provided with a participant information sheet explaining that participation was voluntary, would not affect their care, and could be withdrawn at any time without consequences. Upon agreement to participate, the researcher (MUA) contacted participants to arrange the interviews. The primary researcher (MUA), a male dentist and PhD candidate in Oral Health Sciences with formal training and prior experience in qualitative research, conducted semistructured, in-depth face-to-face interviews. The researcher had no prior clinical relationship with participants. Written informed consent, including consent for audio recording, was obtained from all participants. Interviews were conducted with eight patients, eight family members, and three oral surgeons. Patients were interviewed at home or, in one case where a home interview was not feasible, at a participant-preferred private location (a quiet café setting), while family members and clinicians were interviewed separately. Interview guides were tailored to each participant group. Guides were developed in English, translated into Urdu, and back-translated to ensure accuracy.17 Field notes were used to capture contextual observations and nonverbal cues, and brief member checking was conducted at the end of each interview to confirm key points. Interviews lasted approximately 20 to 30 minutes, considering participants’ clinical condition and the sensitivity of the topic, while allowing sufficient depth of inquiry. Recruitment was challenging due to the rarity of treatment refusal cases, participants’ poor health, and substantial geographic barriers. Data analysis Transcripts were translated and cross-checked against audio recordings and field notes to preserve meaning and cultural nuance. Data were analysed using inductive thematic analysis, informed by procedures for data reduction, display, and verification described by Miles and Huberman.18,19 Initial open coding was conducted to allow themes to emerge from participants’ narratives without the use of a predefined coding framework. Two researchers (MUA, DK) independently coded the transcripts, and discrepancies were resolved through discussion and review of the original recordings. Codes were refined into broader themes, retaining in vivo labels to preserve participants’ voices. Following inductive theme development, pattern matching was used to compare emergent themes with HBM constructs, constituting a theory-informed abductive phase in which empirical themes were interpreted in relation to HBM constructs. This process enabled identification of both convergences and divergences between empirical findings and theoretical constructs, enhancing interpretive depth and internal validity.20 Cross-case comparison among patients, family members, and clinicians strengthened analytic triangulation. A conceptual model was developed to illustrate how the identified themes interacted through unidirectional, bidirectional, and indirect pathways using draw.io software (Figure; Supplementary Figure 2A-G). Core and intertheme pathways underlying hospital-based treatment refusal among oral cancer patients. Trustworthiness Credibility was enhanced through data source triangulation and member checking. Dependability and confirmability were ensured through an audit trail documenting raw data, coding decisions, and analytic memos. The research team repeatedly reviewed transcripts and audio recordings to ensure analytic accuracy. Reflexive memos were used to identify and manage potential researcher bias. Thick description contextualized findings to enhance transferability. Ethical considerations We received ethical approval from the Human Research Ethics Committee, Faculty of Dentistry, Prince of Songkla University (EC6602-009). We obtained written informed consent from all participants prior to data collection. Data confidentiality was ensured through deidentification and secure storage of transcripts and recordings. The study was reported in accordance with the Consolidated Criteria for Reporting Qualitative Research (COREQ) guidelines (Supplementary Table 2).21 Results Participant characteristics A total of 19 in-depth interviews were conducted with eight OC patients who had refused hospital-based treatment, eight family members involved in treatment decision-making, and three oral surgeons. Patient and family characteristics are summarized in Table 1 and Supplementary Table 3, respectively. Patients ranged in age from 25 to 95 years (median 40.5 years); most were married with limited formal education. Patients refused various treatment modalities, including surgery (n = 5), radiotherapy (n = 2), and chemotherapy (n = 1). Surgeons were residents with 2 to 3 years of experience at tertiary care hospitals. Table 1Characteristics of oral cancer patients who refused hospital-based treatment.Table 1 dummy alt textPatient aliasAge (y)GenderResidenceMarital statusOccupationEducation levelHealth insuranceType of treatment refusedCancer stageCancer sitePT195FemaleRuralMarriedHousewifeUneducatedYesSurgeryIVTonguePT235MaleRuralMarriedLabourerPrimaryYesRadiotherapyIIIBuccal mucosaPT346FemaleRuralMarriedHousewifePrimaryNoSurgeryIIIAlveolarPT425FemaleUrbanMarriedHousewifePrimaryYesRadiotherapyIITonguePT528FemaleUrbanMarriedHousewifeSecondaryYesChemotherapyIIIBuccal mucosaPT634MaleUrbanMarriedLabourerSecondaryNoSurgeryIIIFloor of mouthPT749MaleRuralWidowedPrivate JobUneducatedNoSurgeryIIBuccal mucosaPT862MaleUrbanMarriedPrivate JobSecondaryYesSurgeryIIIBuccal mucosaPT, patient. Characteristics of oral cancer patients who refused hospital-based treatment. PT, patient. Overview of major themes Thematic analysis identified seven interconnected themes underlying refusal of hospital-based treatment (Supplementary Table 4; Figure). Six themes mapped directly onto HBM constructs: Perceived Susceptibility, Severity, Benefits, Barriers, Self-Efficacy, and Cues to Action, while a seventh theme, Religious Beliefs, emerged inductively. The frequency and distribution of themes and subthemes across patients, family members, and clinicians are summarized in Table 2. Table 2Frequency and distribution of themes and subthemes mentions by participant type.Table 2 dummy alt textThemeSubthemeType of participantNumber of participant mentioning subthemeFrequency of mentioning% of the subtheme by participantOverall number and % of subthemeOverall number and % of themePerceived susceptibilityBelief in incurable nature of cancerPT1311%7 (17%)41 (9%)FM———HE1450%Cancer is not amenable to hospital treatmentPT82489%34 (83%)FM46100%HE1450%Perceived severityPerceived risks of surgical proceduresPT35159%100 (60%)166 (38%)FM42954%HE32077%Perceived risks of radiotherapyPT31922%35 (21%)FM31018%HE2623%Adverse perceptions of chemotherapyPT31619%31 (19%)FM31528%HE———Perceived benefitsBenefits of treatment refusalPT38100%13 (100%)13 (3%)FM11100%HE24100%Perceived barriersResourcesPT63162%50 (51%)98 (22%)FM71341%HE3638%AccessPT3816%22 (23%)FM51444%HE——Responsibilities and role pressuresPT41020%11 (11%)FM113%HE——Age-related treatment refusalPT112%10 (10%)FM139%HE2637%Lack of awareness about cancer and its treatmentPT———5 (5%)FM113%HE2425%Self-efficacyConfidence in hospital treatment refusalPT616100%20 (100%)20 (5%)FM11100%HE13100%Cues to actionFamily support to refuse treatmentPT8911%21 (22%)94 (22%)FM3975%HE23100%Influence of T&CMPT87089%73 (78%)FM2325%HE———Religious beliefsBelief in destinyPT2267%3 (60%)5 (1%)FM1150%HE———Religious encouragement to seek treatmentPT1133%2 (40%)FM1150%HE———FM, family member; HE, hospital employee; PT, patient; T&CM, traditional and complementary medicine. Frequency and distribution of themes and subthemes mentions by participant type. FM, family member; HE, hospital employee; PT, patient; T&CM, traditional and complementary medicine. Perceived susceptibility Perceived susceptibility emerged as a key driver of treatment refusal, reflected in 41 coded instances (9% of total data). Two related subthemes emerged: a generalized belief in cancer’s incurability and a more specific conviction that hospital treatment is ineffective. The dominant belief, expressed by all eight patients and accounting for 83% of references, was that OC was not amenable to meaningful benefit from hospital-based treatment. Patients cited prior treatment failure, fear of recurrence, and advanced-stage diagnosis as evidence that further intervention was futile. As one patient stated, ‘People don’t always get better with hospital treatment’ (PT4), while others described having ‘lost faith’ after repeated or unsuccessful procedures (PT2, PT8). Advanced disease reinforced this fatalism, with patients and families believing it was ‘too late for surgery’ and that treatment would only prolong suffering without altering outcomes (PT1; HE3). This fatalism extended to broader beliefs that cancer itself was incurable and synonymous with death, regardless of treatment. Patients described cancer as ‘such an incurable disease’ (PT3), questioning, ‘How can you treat an incurable disease, huh?’ (PT3). Clinicians confirmed this pervasive perception, noting that ‘people think that cancer means death’ (HE2). Perceived severity Perceived severity was the most prominent theme, accounting for 166 coded instances (38% of total data), and it reflected intense fears related not only to cancer but, more critically, to treatment-related harm. Three interrelated subthemes emerged: fears related to surgery, radiotherapy, and chemotherapy. Perceived risks of surgery Surgical treatment evoked the strongest fears, with patients frequently viewing surgery as more dangerous than the disease itself. One patient stated that ‘getting treatment was even more dangerous’ (PT3), a perception clinicians also noted: ‘people are quite frightened of surgery’ (HE2). Fear of dying during surgery, often linked to comorbidities, was particularly salient. Patients worried they would not ‘come out (alive) of the operation theater’ (PT3). Concerns about permanent functional loss and disfigurement further deterred acceptance, with patients asking, ‘How will I eat then? Or talk?’ following tongue resection (PT1). Clinicians similarly identified anticipated disfigurement as ‘a significant barrier’ to surgical acceptance (HE3). Fear of anaesthesia emerged as a distinct, culturally reinforced concern. Patients described general anaesthesia as ‘quite dangerous’ (PT3), while surgeons noted that it was a common ‘misconception among people’ (HE3) that they might not come out of anaesthesia. Perceived risks of radiotherapy Concerns about radiotherapy substantially contributed to treatment refusal (35 references; 21% of severity data). It was widely perceived as a debilitating intervention rather than curative, often described as ‘electric shock treatment’ (HE1). Patients reported severe morbidity, including extreme weakness: ‘my face was unrecognizable’ (PT8), and profound xerostomia, described as a mouth ‘dry like a desert’ (PT2). Others refused treatment after observing adverse outcomes in acquaintances, recalling that a neighbour’s condition ‘deteriorated and she died in the end’ following radiotherapy (PT4). Clinicians confirmed these perceptions, noting that many patients view radiotherapy as ‘worse than having no treatment’ (HE3). Perceived risks of chemotherapy Fears about chemotherapy further contributed to treatment refusal (31 mentions; 19% of severity data). One patient stated that chemotherapy ‘didn’t leave any strength in the body’ and felt it ‘kills a person even before the actual time of death’ (PT5). Family members echoed this concern, discontinuing treatment when they perceived it was ‘making her even sicker and that she might not survive it’ (FM5). Perceived benefits Perceived benefits of refusing hospital-based treatment were infrequently cited (13 instances; 3%) but centred on preserving quality of life and avoiding further suffering, particularly in advanced disease. Patients described physical improvement after discontinuing treatment: ‘Now after I have stopped the treatment, I feel like I am getting my strength back’ (PT5) and viewed home-based care as preferable: ‘Yes, absolutely. Home treatment is much better’ (FM1). Clinicians acknowledged this rationale when prognosis was poor, noting, ‘We know that she doesn’t have many days left, so we think that not doing the surgery is the best option’ (HE1). Elderly patients similarly questioned the value of aggressive intervention, asking, ‘What’s the point of getting such complex treatment after I’ve almost reached the end of my life?’ (HE2). Perceived barriers Practical, financial, and social obstacles constituted a major theme (98 mentions; 22% of data). Five interrelated subthemes emerged: resource barriers, access barriers, role pressures, age-related considerations, and lack of awareness. Resource barriers Financial hardships were most prominent (51% of barrier data). Patients described treatment costs as catastrophic: ‘I got into a lot of debt due to the expenses for the treatment’ (PT2), with uninsured and refugee families reporting care was entirely ‘out of our reach’ (FM7). Clinicians confirmed that even subsidized treatment ‘could not be afforded by them’ (HE1). Access barriers Geographic distance and systemic delays further deterred care. Patients highlighted prolonged initiation processes: ‘It takes a lot of time to get the hospital treatment started’ (PT2) and the physical strain of repeated travel while ill: ‘A person is already sick… and then you have to travel every day… which makes the condition even worse’ (PT5). Responsibilities and role pressures Treatment conflicted with essential social roles. Women feared abandoning caregiving responsibilities, particularly in the context of perioperative death: ‘My home and my children will be left behind me’ (PT3). Male patients, often primary earners, faced loss of livelihood: ‘It is impossible for me to skip work; otherwise, there will be no food’ (PT6). Age-related treatment refusal Elderly patients frequently refused treatment based on perceived limited life expectancy and diminished benefit. A 95-year-old patient questioned, ‘What is the point in treatment?’ (PT1). Lack of awareness Limited cancer knowledge underpinned many barriers. As one clinician noted, ‘People don’t know anything about cancer; they don’t know the signs and symptoms, the treatment options, or even the prognosis’ (HE2). Perceived self-efficacy Patients’ confidence in refusing hospital-based treatment emerged as a distinct theme (20 instances; 5% of data). Many expressed strong conviction in their decision, often grounded in prior negative experiences with biomedical care and cultural familiarity with alternative therapies. One elderly participant stated emphatically, ‘No … I will never do that operation … I am better without it’ (PT1). Others linked refusal directly to treatment burden, describing chemotherapy as intolerable: ‘Refusal is better than receiving the drops’ (chemotherapy) treatment (PT5). For some, refusal reflected a desire to preserve autonomy and dignity at the end of life: ‘At least I will spend my last days at my home’ (PT1), while patients with recurrence expressed firm resolve, stating, ‘I will not go back for the same old treatment at the hospital’ (PT2). This confidence persisted even in the face of family pressure, as one husband noted, ‘Even I tried to convince her, but she refused’ (FM3). Clinicians corroborated this pattern, observing that ‘Sometimes they believe in alternative treatment much more than hospital treatment’ (HE3). Cues to action External cues strongly reinforced treatment refusal, accounting for 94 coded instances (22% of total data). Two dominant influences emerged: family support for refusal and reliance on T&CM. Family support to refuse treatment Family members frequently validated and reinforced patients’ reluctance towards hospital-based care. One patient stated, ‘My daughters and my sons also told me to not do the operation’ (PT1). Decisions were often collective rather than individual, as reflected by a grandson: ‘It’s actually a unanimous decision … all her heirs have made this decision’ (FM1). Clinicians confirmed this powerful dynamic, noting that families would sometimes collectively refuse treatment, believing it was ‘too late for surgery’ (HE3). Influence of T&CM T&CM was the most prominent cue to action, cited 73 times (78% of this theme). Deep cultural and spiritual trust positioned T&CM as a credible alternative to biomedical care. Patients expressed strong belief in its curative potential: ‘It will completely cure me’ (PT8), while family members viewed it as ‘better than hospital treatment’ (FM8). Surgeons observed that patients ‘strongly believe in spiritual healing or amulets more than in scientific treatment’ (HE3). Perceived effectiveness further reinforced this choice, with patients reporting visible improvements: ‘The wound is also becoming drier … it has reduced in size and is disappearing’ (PT2). T&CM was perceived as ‘natural and non-toxic’ (PT5), compared with the ‘toxic effects of hospital treatment’ (PT4). Its accessibility and affordability were decisive: ‘Receiving this treatment is easy and doesn’t present many obstacles’ (PT2), and ‘The Hakeem is my neighbor… it saved me time and money’ (PT6). Religious beliefs Religious beliefs provided a foundational framework for understanding illness and legitimizing treatment decisions. This theme revealed how faith in divine will (Taqdeer) and the concept of healing as a religious practice (Sunnah) shaped patients’ pathways, often directing them towards faith-based or traditional healing as religiously congruent alternatives to hospital care. Two interrelated subthemes emerged: belief in divine destiny (Taqdeer) and religious encouragement to seek treatment (Sunnah). Belief in destiny Many participants viewed cancer outcomes as divinely predetermined, fostering acceptance and reducing perceived urgency for hospital treatment. As one patient stated, ‘Whatever is written in my Taqdeer (Destiny) … It will become better … In sha Allah … Nothing is difficult for Him’ (PT1). Patients attributed ultimate healing to Allah: ‘If Allah wills, I will get better. … It is not the person (faith healer) but Allah who cures the disease’ (PT8). Family members echoed this conviction: ‘We will ask for peace from Allah. Ultimately everything is in His hands’ (FM8). Religious encouragement to seek treatment Conversely, some participants invoked Islamic teachings to justify seeking treatment, though not necessarily in a hospital. Patients cited Prophetic tradition to legitimize care-seeking: ‘It is a Sunnah to get treatment because our Prophet (Peace Be Upon Him) got treated as well’ (PT3), a view shared by another pursuing Hakeem treatment who stated, ‘I am following the Sunnah of getting treatment’ (PT4). Faith-based practices were framed as religiously valid alternatives, with one patient explaining, ‘Faith healing is also a type of treatment… all of it is made of recitation and Qur’anic verses, which is also a Sunnah’ (PT2). A family member further clarified that it is a ‘misconception that there is no concept of doctors in Islam’ (FM1). Discussion We explored the beliefs and decision-making processes underlying refusal of hospital-based treatment among OC patients in Pakistan, using the HBM as a guiding framework. The findings support the utility of the HBM, showing that refusal represents an interconnected process in which illness perceptions, anticipated treatment consequences, sociocultural influences, and structural constraints jointly shape decisions. Rather than passive nonadherence, refusal emerged as a reasoned response shaped by social and economic circumstances. Decisions were oriented towards minimizing suffering, preserving functional and social roles, and pursuing care pathways perceived as more acceptable, culturally familiar, or practically feasible. These findings offer important insights for stakeholders that may inform the design of culturally responsive health interventions and support improved communication and shared decision-making in OC care. Religious beliefs functioned as a cross-cutting contextual construct that both reinforced and modified core HBM pathways. They provided an existential script for accepting fate (Taqdeer) while simultaneously legitimizing the pursuit of healing, often interpreted to include spiritual and traditional modalities beyond hospital care. This aligns with prior studies showing the profound impact of religiosity on decision-making among Muslim cancer patients.22,23 The belief in divine will frequently encouraged passive acceptance, framing cancer as a predetermined test and reinterpreting refusal not as negligence but as a pious act of submission to divine timing.2,22 Yet religious interpretation was not monolithic. A contrasting narrative invoked Islamic teachings that encourage seeking treatment, with participants citing Prophetic traditions (Sunnah) as justification for pursuing care.24 This duality illustrates the interpretive flexibility of religious doctrine and underscores the potential value of engaging trusted religious leaders to counter fatalistic misconceptions and support timely biomedical treatment. The central mechanism underlying refusal was the reinterpretation of treatment through a risk–benefit lens. Hospital-based care was widely perceived as offering limited likelihood of cure while carrying substantial risks of physical suffering, functional loss, disfigurement, or treatment-related death. Perceived severity was directed less towards the disease itself and more towards anticipated treatment-related harm, particularly among patients presenting at advanced stages.11,25 Fatalistic beliefs that cancer is inherently incurable further reduced expectations of treatment effectiveness, reinforcing perceptions of treatment futility rather than potential benefit.26,27 This interpretation is consistent with our earlier findings linking fatalism to delayed care-seeking.2 In this context, perceived treatment risk outweighed anticipated therapeutic gain, and perceived benefits were reframed in terms of preserving strength, dignity, and daily functioning rather than prolonging survival.11 For many participants, refusal therefore represented an intentional effort to protect quality of life rather than a rejection of care itself. Treatment refusal also appeared to vary according to clinical stage and the type of treatment refused. Patients with advanced disease often perceived treatment as unlikely to provide meaningful benefit, particularly when treatment was associated with anticipated pain, disfigurement, functional impairment, or severe toxicity.9,10,25,28 Healthcare system challenges, including delays, repeated hospital visits, and difficulties navigating care pathways, further reinforced refusal decisions.28 Interactions with healthcare professionals also influenced treatment perceptions, particularly when patients felt unprepared for the anticipated consequences of treatment.25 Collectively, these findings suggest that treatment refusal is shaped not only by individual beliefs but also by broader clinical and healthcare-system experiences. Structural and social constraints further shaped treatment decisions by limiting the feasibility of sustained hospital care. Financial hardship, long travel distances, and health system delays imposed substantial practical burdens, even when subsidized services were available. These constraints were compounded by gendered role expectations, with women prioritizing caregiving responsibilities and men concerned about loss of income. Among older patients, limited perceived life expectancy further reduced the perceived value of aggressive treatment.4,28 Rather than reflecting individual reluctance, these patterns indicate that refusal often represented a pragmatic response to structural vulnerability and competing social obligations, consistent with evidence highlighting the influence of socioeconomic constraints on cancer treatment decisions. Treatment refusal was rarely an individual decision but was socially negotiated and reinforced. Family members frequently validated or encouraged refusal, reflecting collective decision-making norms. Confidence in rejecting biomedical care was further strengthened by cultural familiarity with T&CM, which was widely perceived as accessible, safer, and more aligned with local beliefs.29, 30, 31 Within this social environment, refusal became a socially endorsed and practically supported pathway rather than a deviation from normative care. Similar patterns have been reported in Pakistan and other settings, where reliance on T&CM and family influence shape treatment choices and contribute to delays or discontinuation of biomedical care.1 These findings are consistent with prior applications of the HBM across diverse health contexts. Studies on HPV vaccination have shown that refusal is strongly influenced by perceived barriers and limited perceived benefits.32 Similarly, nonadherence to antihypertensive therapy has been associated with perceived severity, susceptibility, and barriers, while perceived benefits and cues to action promote treatment acceptance.33 Evidence from paediatric chronic illness further demonstrates that multiple HBM constructs jointly influence adherence to complex treatment regimens among children with cystic fibrosis.34 Collectively, this literature supports the capacity of the HBM to explain treatment refusal as a rational, belief-driven health behaviour rather than an irrational deviation from medical recommendations. To the best of our knowledge, this is one of the first qualitative studies focused specifically on OC treatment refusal, offering insights into a rare yet clinically significant phenomenon. Methodological rigour was strengthened through member checking, audit trails, data source triangulation, and reflexivity. Application of the HBM provided a structured interpretive framework for examining treatment refusal within its sociocultural context. We acknowledge several limitations when interpreting the findings. Only one family member per patient was included, which may have limited the breadth of familial perspectives. The findings are context-specific, with transferability influenced by the small sample size and the predominantly Muslim, low-socioeconomic setting. In addition, the sensitive nature of religious and cultural beliefs may have constrained full disclosure, despite efforts to build rapport and ensure confidentiality. As with all interview-based studies, the findings reflect participants’ self-reported beliefs and may not capture unarticulated or socially sensitive motivations. Conclusion Refusal of hospital-based OC treatment in Pakistan reflects a coherent, culturally grounded decision shaped by fears of treatment-related suffering, structural constraints, family influence, and spiritually sanctioned alternatives. Rather than being driven solely by misinformation, refusal arises from the convergence of sociocultural, religious, and systemic factors that shape how patients interpret illness and care. The findings also demonstrate the utility of the HBM in organizing and interpreting these complex decision-making processes within their sociocultural context. Stakeholders in oral oncology may use these insights to inform the development of culturally responsive communication and patient-centred interventions. Ethics statement and informed consent Ethical approval was obtained from the Human Research Ethics Committee, Faculty of Dentistry, Prince of Songkla University (EC6602-009). Written informed consent was obtained from all participants. Declaration of generative AI and AI-assisted technologies in the writing process Generative artificial intelligence–assisted software (DeepSeek, 2025) was used solely to support visualization of the conceptual model illustrating thematic relationships. All analytical decisions, interpretations, and conclusions were made by the authors. No generative AI tools were used in data analysis, interpretation, or manuscript writing. Funding This study is from the doctoral dissertation research of the first author (MUA). Funding for the study was provided by the Faculty of Dentistry and the Graduate School, Prince of Songkla University, Thailand. Data availability The data supporting the findings of this study are available from the corresponding author upon reasonable request. Conflict of interest The authors have no conflicts of interest relevant to this article. Acknowledgements The authors thank all participants for generously sharing their time and experiences. Footnotes Supplementary material associated with this article can be found in the online version at doi:10.1016/j.identj.2026.109701. Contributor Information Supawadee Naorungroj, Email: supawadee.n@psu.ac.th. Duangporn Kerdpon, Email: duangporn.ke@gmail.com. Supplementary materials REFERENCES Associated Data Supplementary Materials Data Availability Statement The data supporting the findings of this study are available from the corresponding author upon reasonable request.